Kevin C. Oboyle - 03 Jun 2026 Form 4 Insider Report for CARLSMED, INC. (CARL)

Reporting relationship: Director
Issuer ticker: CARL
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 06:13:31 UTC
Prior SEC filing: 29 May 2026
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Leonard Greenstein, as attorney-in-fact for Kevin O'Boyle

Key filing fact

Kevin C. Oboyle filed Form 4 for CARLSMED, INC. (CARL) on 22 Jun 2026.

Key facts

This page summarizes Kevin C. Oboyle's Form 4 filing for CARLSMED, INC. (CARL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 06:13.

Change

Previous filing in this sequence was filed on 29 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001203567 Primary reporting owner

OBOYLE KEVIN C

Relationship: Director
Address: C/O CARLSMED, INC., 1800 ASTON AVE., SUITE 100, CARLSBAD
Signature: /s/ Leonard Greenstein, as attorney-in-fact for Kevin O'Boyle
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARL transaction

Common Stock

Award

Transaction value
Shares: +13,698
Change %: +79%
Price: $0.000000^*
Shares after: 31,031
Date: 03 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Constitutes an award of restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in full on the earlier of (i) the day before the Issuer's 2027 annual meeting of stockholders or (ii) June 3, 2027, subject, in all cases, to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.